Introduction: Clostridium perfringens is a gram positive pathogen which is an etiological agent in Clostridial myonecrosis and enteritis necroticans. Unless promptly treated, C. perfringens infections may result in tissue necrosis and death. Syzygium australe (brush cherry) and Syzygium luehmannii (riberry) fruit and leaves have documented therapeutic properties as general antiseptic agents against an extensive panel of bacteria. Despite this, studies are yet to test the growth inhibitory activity of these species against C. perfringens. Methods: S. australe and S. luehmannii fruit and leaf extracts were investigated by disc diffusion assay for growth inhibitory activity against a clinical strain of Clostridium perfringens. Their MIC values were determined to quantify and compare their efficacies. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: Methanolic and aqueous S. australe and S. luehmannii fruit and leaf extracts as well as the corresponding fruit ethyl acetate extracts, displayed growth inhibitory activity in the disc diffusion assay against C. perfringens. The aqueous and methanolic extracts were particularly potent growth inhibitors, each with MIC values substantially <500 µg/mL. The S. australe fruit extracts were nontoxic in the Artemia franciscana bioassay (LC 50 values <1000 µg/mL). All ethyl acetate extracts were also nontoxic. In contrast, the S. luehmannii aqueous and methanolic extracts (fruit and leaf), as well as the S. australe leaf extracts displayed substantial toxicity in the assay. Conclusion: The potent growth inhibitory bioactivity of the fruit and leaf aqueous and methanolic Syzygium spp. extracts against C. perfringens indicates their potential as medicinal agents in the treatment and prevention of clostridial myonecrosis and enteritis necroticans.
INTRODUCTION
The genus Clostridium comprises a large group of sporulating, Grampositive, fermentative saprophytes. Generally existing in nature as part of the natural bacterial flora, the genus is clinically significant as several members of the genus have been linked to a number of diseases in humans.These include C. botulinum (botulism), C. difficile (pseudomembranous colitis), C. sordellii (pneumonia, endocarditis) and C. perfringens (food poisoning, clostridial myonecrosis).
1,2 Although non-invasive, pathogenic clostridia are opportunistic and under suitable conditions can infect a host and cause disease through the production of various exotoxins. 3 The diseases vary greatly in both associated symptoms and degree of lethality, and some species can cause multiple diseases depending on the route of infection. The best known example within the genus is C. perfringens, which can cause food poisoning if ingested, or clostridial myonecrosis (gas gangrene) through the infection of deeptissue wounds. 4 C. perfringens is one of the most common causes of food poisoning, accounting for up to a million infections annually in the United States. 5 Present in air, soil, water, faeces and as part of the human gut microbiota, the bacterium commonly infects food and at ambient temperatures can propagate to infectious levels. Whilst proper food preparation can significantly reduce the likelihood of infection, the sporulating nature of C. perfringens can result in the organism's survival. 6 In fact, C. perfringens is reportedly the second most common cause of bacterial food poisoning, with only by nontyphoidal Salmonella causing more cases. 5 Antibiotic therapy can offer an effective means of treatment, however due to the potential development of bacterial resistance, the search is ongoing for alternative antimicrobial agents. In addition to the design and synthesis of new agents, the probing of natural resources for antimicrobial agents offers an appealing alternative to traditional means of drug development. The geographical isolation and unique flora positions Australia to be an ideal environment for such investigations with several previous studies reporting antimicrobial activity against a number of other microorganisms. 7 Syzygium (family Myrtaceae) is a genus of flowering plants which comprises approximately 500 species. 8 Syzygium spp. are widespread globally, occurring in tropical and subtropical regions of Africa, Southern and South-East Asia, and throughout Australia. The greatest diversity of Syzygium spp. occurs in South-East Asia and Northern Australia. Most species are evergreen trees or large shrubs, with glossy green foliage. Several species have culinary and therapeutic uses. In the commercially most important species Syzygium aromaticum (clove), the unopened flower bud is used as a spice. This plant also has uses in traditional medicine due to its anaesthetic properties. 9 The antibacterial activity of S. aromaticum is also well known. Numerous studies have reported on the antibacterial 10 and antifungal 11 activities of oils and extracts from this plant. 20 Furthermore, recent studies have also reported antibacterial activity in extracts from high antioxidant Australian plants. [21] [22] [23] [24] Particularly noteworthy, the Australian species S. australe (Bush Cherry) and S. luehmannii (Riberry) have potent growth inhibitory activity against a broad panel of bacteria. 25, 26 However, despite the reported broad spectrum growth inhibitory activity of Australian Syzygium spp., numerous pathogens are yet to be evaluated for their susceptibility to Australian Syzygium spp. extracts. The current study was undertaken to test the ability of to S. australe and S. luehmannii fruit and leaf extracts to inhibit the growth of the Gram-positive anaerobic bacterium Clostridium perfringens.
MATERIALS AND METHODS

Plant source and extraction
S. luehmannii and S. australe fruit and leaves were collected from verified trees in suburban regions of Brisbane, Australia and voucher specimens deposited in the School of Natural Sciences, Griffith University, Australia. The plant materials were comprehensively dried using a Sunbeam food dehydrator and the dried material stored at -30 o C until required. Prior to use, the plant materials were thawed and ground into a coarse powder. Individual 1 g quantities of the ground plant material were weighed into separate tubes and 50 mL of deionised water, methanol or ethyl acetate were added. All solvents were obtained from Ajax, Australia and were AR grade. The ground plant materials were independently extracted in each solvent for 24 h at 4 o C through gentle shaking. The extracts were subsequently filtered through filter paper (Whatman No. 54) under vacuum, followed by drying using rotary evaporation in an Eppendorf concentrator 5301. The resultant dry extract was weighed and dissolved in 10 mL deionised water (containing 1% DMSO).
Qualitative phytochemical studies
Phytochemical analysis of the extracts for the presence of alkaloids, cardiac glycosides, tannins, saponins, phenolic compounds, flavonoids, polysteroids and triterpenoids was achieved as previously described.
27-29
Antioxidant capacity
The antioxidant capacity of each sample was assessed using a modified DPPH free radical scavenging method. 30, 31 Ascorbic acid (0-25 µg per well) was used as a reference and the absorbances were measured and recorded at 515 nm. All tests were completed alongside controls on each plate and all were performed in triplicate. The antioxidant capacity based on DPPH free radical scavenging ability was determined for each extract and expressed as µg ascorbic acid equivalents per gram of original plant material extracted.
Antibacterial screening Clinical Clostridium perfringens screening
A clinical strain of Clostridium perfringens was supplied by Ms. Jane Gifkins (Griffith University) which was originally isolated and verified by Dr. John Bates (Department of Health, Queensland, Australia). Cultures were grown and maintained using a thioglycollate liquid media (Oxoid Ltd., Australia). All growth studies were performed using nutrient agar (Oxoid Ltd., Australia) under induced anaerobic conditions through the use of anaerobic jars and AnaeroGen™ 3.5 L atmospheric generation systems (Thermo Scientific). All studies were performed at 30 o C and the stock culture was subcultured and maintained in thioglycollate liquid media at 4 o C.
Evaluation of antimicrobial activity
Antimicrobial activity of Syzygium spp. extracts was determined using a modified disc diffusion assay. 23, 30 Briefly, 100 µL of C. perfringens was grown in 10 mL of fresh thioglycollate media until an approximate count of 10 8 cells/mL was reached. A volume of 100 µL of the bacterial suspension was spread onto nutrient agar and extracts were tested for antibacterial activity using 6 mm sterilised filter paper discs. Discs were impregnated with 10 µL of the extracts, allowed to dry and placed onto the inoculated plates. The plates were left to stand at 4°C for 2 h before incubation at 30°C for 24 h. The diameters of the inhibition zones were measured to the closest whole millimetre. Each assay was performed in at least triplicate. Mean values (± SEM) are reported in this study. Standard discs of penicillin (2 µg) and ampicillin (10 µg) were obtained from Oxoid Ltd., Australia and used as positive controls to compare antibacterial activity. Filter discs impregnated with 10 µL of distilled water were used as a negative control.
Minimum inhibitory concentration (MIC) determination
The minimum inhibitory concentrations (MIC) of the extracts was determined as previously described. 32, 33 Briefly, the plant extracts were diluted in deionised water and tested across a range of concentrations. Discs were impregnated with 10 µL of the extract dilutions, allowed to dry and placed onto inoculated plates. The assay was performed as outlined above and graphs of the zone of inhibition versus concentration were plotted. Determination of MIC values were achieved using linear regression.
Toxicity screening
Reference toxin for toxicity screening Potassium dichromate (K 2 Cr 2 O 7 ) (AR grade, Chem-Supply, Australia) was prepared in deionised water (4 mg/mL) and serially diluted in artificial seawater for use in the Artemia franciscana nauplii bioassay.
Artemia franciscana nauplii toxicity screening
Toxicity was tested using a modified Artermia franciscana nauplii lethality assay. [34] [35] [36] Briefly, 400 µL of seawater containing ~43 (mean 43.2, n=155, SD 14.5) A. franciscana nauplii were added to wells of a 48 well plate and immediately used in the bioassay. Volumes of 400 µL of reference toxin or the diluted plant extracts were transferred to the wells and incubated at 25 ± 1°C under artificial light (1000 Lux). For each plate, a negative control (400 µL seawater) was run in triplicate. All treatments were also performed in at least triplicate. The wells were assessed at regular intervals and the number of dead counted. The nauplii were deemed dead if no movement of the appendages was detected within 10 sec. After 24 h, all nauplii were sacrificed and counted to determine the total % mortality per well. The LC 50 with 95% confidence limits for each treatment was calculated using probit analysis.
Statistical analysis
Data is expressed as the mean ± SEM of at least three independent experiments.
RESULTS
Liquid extraction yields and qualitative phytochemical screening
Extraction of Australian Syzygium spp. plant materials (1 g) with various solvents yielded dried plant extracts ranging from 62 mg (S. luehmannii leaf ethyl acetate extract) to 560 mg (S. luehmannii fruit methanolic extract) ( Table 1) . Methanolic extracts provided significantly greater yields of extracted material relative to the corresponding aqueous and ethyl acetate extracts, which gave low to moderate yields. The dried extracts were resuspended in 10 mL of deionised water (containing 1% DMSO), resulting in the concentrations presented in Table 1 .
Antioxidant content
Antioxidant capacity for the plant extracts (Table 1 ) ranged from 1.5 mg (S. luehmannii fruit ethyl acetate extract) to a high of 94.6 mg ascorbic acid equivalence per gram of dried plant material extracted (S. luehmannii fruit methanolic extract). The antioxidant capacities for the aqueous and methanolic extracts of each plant part were generally similar for both species and were substantially higher than the corresponding ethyl acetate extracts.
Antimicrobial activity
To determine the ability of the crude fruit and leaf extracts to inhibit C. perfringens growth, 10 µL of each extract were screened using a disc diffusion assay. Bacterial growth was inhibited by 10 of the 12 extracts screened (83%) (Figure 1 ). The methanolic extracts were the most potent inhibitor of growth (as judged by zone of inhibition), with inhibition zones as much as 19.3 ± 0.6 mm (S. australe fruit methanolic extract). This compares favourably with the penicillin (2 µg) and ampicillin controls (10 µg), with the zones of inhibition of 12.3 ± 0.3 and 13 ± 1.0 mm respectively. Indeed, the methanolic fruit and leaf extracts of both Syzygium spp. displayed inhibition zones > 12 mm. The aqueous S. australe fruit and S. luehmannii leaf extracts also displayed good inhibition of C. perfringens growth with >10 mm zones of inhibition. The antimicrobial efficacy of the extracts was further quantified through the determination of MIC values ( Table 2 ). The aqueous and methanolic fruit extracts of both Syzygium spp., were particularly effective at inhibiting C. perfringens growth with MIC values generally <300 µg/mL (<3 µg impregnated in the disc). Similarly, the aqueous and methanolic S. luehmannii leaf extracts, as well as the methanolic S. australe leaf extract, were good growth inhibitors with MIC values <900µg/mL (<9 µg infused into the disc). These results compare well with the growth inhibitory activity of the penicillin and ampicillin controls which were tested at 2 µg and 10 µg respectively. All other extracts were either of only low efficacy in the assay, or did not inhibit C. perfringens growth at all.
Quantification of toxicity
All extracts were initially screened in the assay at 2000 µg/mL ( Figure 2) . As a reference toxin, potassium dichromate was also tested in the bioassay. The potassium dichromate reference toxin was rapid in its onset of mortality, inducing nauplii death within the first 3 h of exposure and 100% mortality was evident within 4-5 h (unpublished results). With the exception of the ethyl acetate leaf extracts of both species, all extracts showed > 50% mortality rates at 24 h. To further quantify the effects of toxin concentration on Artemia nauplii mortality, the extracts were serially diluted in artificial seawater to test across a series of concentrations in the Artemia nauplii bioassay. The 24 h LC 50 values of the Syzygium spp. extracts towards A. franciscana are presented in Table 2 . No LC 50 values are reported for the fruit or leaf ethyl acetate extracts of either species as <50% mortality was seen in all tested concentrations. Extracts with an LC 50 >1000 μg/mL towards Artemia nauplii have been defined as being nontoxic. 37 The S. australe fruit methanolic and aqueous extracts also both had LC 50 values substantially >1000 μg/mL and were therefore deemed to be non-toxic. Interestingly, the aqueous and methanolic extracts of S. australe leaf and of S. luehmannii fruit and leaf, displayed LC 50 values substantially <1000 μg/mL and were therefore considered toxic. This was a surprising result as S. australe and S. luehmannii fruit are considered nutritious, high antioxidant foods. However, it is noteworthy that the bioassay organism (Artemia franciscana) is sensitive to extreme pH ranges. Our study reported that all of the extracts with LC 50 values < 1000 μg/mL had relatively high antioxidant capacities. Furthermore, previous studies 14 reported that the high antioxidant capacities of these Syzygium spp. is largely due to their high ascorbic acid contents. Therefore, it is possible that the apparent toxicity reported in this study may instead be a result of the extracts high ascorbic acid contents.
DISCUSSION
Previous studies have reported potent growth inhibitory activities for S. australe and S. leuhmannii fruit and leaf extracts against a panel of pathogenic bacterial species. 25, 38, 39 Both Gram-positive and Gramnegative bacteria were screened in previous studies. Whilst the Syzygium spp. extracts had broad spectrum growth inhibitory activity, a greater susceptibility of Gram-positive bacteria was noted. Indeed, the previous studies reported that the aqueous and methanolic S. australe and S. leuhmannii extracts inhibited the growth of 40-80% of the gram positive bacterial species tested, with the methanolic extracts generally having a broader specificity. In light of this broad spectrum gram positive growth inhibitory activity, the potent C. perfringens growth inhibition evident in our study is perhaps not surprising. Whilst an investigation of the phytochemistry of the Syzygium spp. extracts was beyond the scope of our study, high flavonoid, terpenoid and tannin contents are characteristics of this genus. 40, 41 Flavonoids have well established bacterial growth inhibitory activities. 42 Relatively high levels of kaempferol and myricetin have been reported in leaf extracts from the taxonomically related species Syzygium aromaticum (clove). 9 The same study also reported potent growth inhibitory activity for pure kaempferol, myricetin and a methanolic S. aromaticum leaf extract against a panel of bacteria. Similarly, quercetin, rutin and their corresponding glycosides inhibit the growth of Pseudomonas maltophilia and Enterobacter cloacae. 43 The antimicrobial activity of terpenoids hasbeen extensively documented. Monoterpenoids including α-pinene, β-pinene, sabinene, mycrene, terpinene, limonene, piperitone and β-phellandrene inhibit the growth of a panel of bacteria including several nitrofurantoin resistant strains of Enterobacteriaceae. 42 Similarly, the antibacterial activities for several sesquiterpenoids including α-cubebene, copaene and caryophyllene have been reported. 42 Furthermore, many tannin compounds have bacterial growth inhibitory activity. Gallotannins inhibit the growth of a broad spectrum of bacterial species 44 through a variety of mechanisms including binding cell surface molecules including lipotoichoic acid and proline-rich cell surface proteins, 45, 46 and by inhibiting glucosyltransferase enzymes. 47 Elligitannins are also highly potent inhibitors of bacterial growth, with MIC values as low as 62.5 µg/ml. 44, 46 Ellagitannins have also been reported to function via several antibiotic mechanisms including interaction with cytoplasmic oxidoreductases and by disrupting bacterial cell walls. 44, 46 Thus, it is likely that multiple compounds within the Syzygium spp. extracts are contributing to the growth inhibition of C. perfringens. The findings reported here also indicate that the majority of the Syzygium spp. extracts examined in this study displayed significant toxicity (<1000 µg/mL) in the Artemia nauplii bioassay. Indeed, the most promising aqueous and methanolic S. luehmannii fruit extracts (MIC values of 275 and 161 µg/mL respectively) had LC 50 values of approximately 450 µg/mL, indicating moderate to high toxicity. This toxicity would impact on the usefulness of these extracts as a medicinal antiseptic agent. Similar extracts prepared from fruits of these species have previously been reported to have high ascorbic acid levels. 13, 14 Whilst these ascorbic acid levels may have beneficial therapeutic effects, they may also be responsible (at least in part) for the toxicity reported here. Whilst A. franciscana have generally been reported to be a robust and hardy organism for toxicity screening, they are susceptible to pH changes. 37 The levels of ascorbic acid previously reported in S. australe and S. leuhmannii extracts 13, 14 would be expected to have a significant impact on the pH of the seawater in the tests and this change may be responsible for the mortality induction reported in our study.Indeed, studies in our laboratory have shown that testing pure ascorbic acid in the concentrations previously reported to be in these extracts results in mortality similar to that reported in our study (unpublished results). Whilst toxicity was assessed in this study with the test organism A. franciscana, toxicity towards A. franciscana has previously been shown to correlate well with toxicity towards human cells for many toxins. 37 However, further studies are required to determine whether this is also true for the Syzygium spp. extracts examined in these studies. Toxic anti bacterial extracts may still be useful as non-medicinal antibacterial agents (eg. surface disinfectants and topical antiseptics). Likewise, toxic plant extracts may also still have medicinal potential even if they are not antimicrobial. Previous studies have demonstrated that toxicity in the A. franciscana bioassay may indicate anti-cancer potential. 37 Indeed, the anti-proliferative activity of S.australe and S. luehmannii fruit and leaf extracts has been reported against CaCo2 and HeLa human cancer cell lines, 12 indicating that these extracts may also have potential in the development of new anticancer drugs. The results of this study indicate that the Syzygium spp. extracts examined warrant further study due to their C. perfringens growth inhibitory activity. Conversely, the toxicity detected for these extracts indicates Pharmacognosy Communications, Vol 6, Issue 2, Apr-Jun, 2016 that further toxicity studies are required to evaluate the safety of these extracts for medicinal usage. Whilst the extracts examined in this report have potential as C. perfringens growth inhibitory agents, caution is needed before these compounds can be applied to medicinal purposes. Purification and identification of the bioactive components is needed to examine the mechanisms of action of these agents.
CONCLUSION
The results of this study demonstrate the potential of S. australe and S. leuhmannii fruit and leaf extracts to inhibit C. perfringens growth. As the fruit and leaves of these Syzygium species are edible and are used as a culinary agent, they have potential in the prevention and treatment of clostridial myonecrosis and enteritis necroticans. However, before being acceptable for therapeutic uses, further cell line toxicity studies are required to verify the safety of these extracts. Furthermore, studies aimed at the purification and identification of the bioactive components arerequired to examine the mechanisms of action of these extracts.
